Fever After Allergy Shot: What the Data Shows and When to Seek Care

Low-grade temperature elevation after an allergy shot is anecdotally reported but has no published prevalence figure in peer-reviewed SCIT safety literature. Cox 2011 PP3, Bernstein 2008 JACI, and Epstein 2013/2014 surveillance do not track fever as an endpoint. The mechanism — cytokine release from immune activation producing transient constitutional symptoms — is plausible but unquantified for conventional aqueous SCIT. If your temperature is below 100.4°F (37.8°C) and resolves within 24 hours without other symptoms, this is likely benign. True fever (≥100.4°F) or temperature elevation persisting beyond 24 hours warrants a call to your allergist's office.

Allergy shots introduce allergen extract into subcutaneous tissue, triggering an immune response involving mast cell activation, T-cell engagement, and cytokine release. Pro-inflammatory cytokines including IL-6 and TNF-alpha can produce constitutional symptoms including low-grade temperature elevation in immune-activation contexts. Antihistamines work by blocking histamine receptors — they do not involve any immune activation and carry no mechanism for producing fever. The comparison highlights a fundamental difference in how the two interventions work: antihistamines suppress a symptom; allergy shots attempt to reprogram the underlying immune response, which involves some degree of immune activation during the treatment period.

Call your allergist if: fever is above 101°F (38.3°C); fever persists beyond 24 hours; fever is accompanied by any localized pain suggesting infection (ear pain, sinus pressure, chest pain, abdominal pain); or fever is accompanied by ANY new symptom outside the injection arm (hives, throat sensation, wheeze, lightheadedness). Seek emergency care immediately if fever accompanies generalized hives, throat tightness, difficulty breathing, or lightheadedness — this constellation is a grade 3-4 systemic reaction requiring epinephrine and 911, not a constitutional response to the injection. For mild low-grade temperature (99-100°F) resolving within a few hours without other symptoms, a message to your allergist's office — rather than an urgent call — is appropriate.

This is a common and understandable confusion, but the two are mechanistically different. Vaccines are designed to provoke systemic immune activation, often using adjuvants that stimulate the innate immune system broadly — this is intentional and produces the predictable post-vaccination fever documented in clinical trials for each vaccine product. SCIT allergen extracts are designed to induce immune tolerance via T-regulatory cells, not to provoke acute systemic inflammation. SCIT extracts do not contain the immunostimulatory adjuvants that drive post-vaccination fever. Whether SCIT injections cause fever and at what prevalence is simply not measured in the SCIT safety literature — it is an evidence gap, not a clean 'no.'

Receiving an allergy shot while actively febrile is generally not recommended. Active infection or systemic illness increases baseline immune activation, which may increase the risk or severity of a post-injection systemic reaction. Cox 2011 PP3 recommends deferring injections when patients have active asthma symptoms or significant illness. Most allergy practices apply similar logic to fever: if you have a temperature ≥100.4°F on the day of your injection appointment, contact your clinic to reschedule rather than proceeding with the shot. This protects both your safety and the accuracy of any post-injection reaction observation. Missing a single injection visit during maintenance typically requires a minor dose reduction on the rescheduled visit per Cox 2011 PP3 guidelines.

A clinical threshold that warrants action: true fever is defined as ≥100.4°F (38°C). Temperature below this threshold (99-100°F) is sometimes called a low-grade temperature and may be within the range of normal variation and mild immune activation. Temperature at or above 100.4°F warrants a call to your allergist's office. Temperature above 101°F (38.3°C) or fever persisting beyond 24 hours is more likely to reflect a coincident infection than a shot reaction, because the mechanism by which allergy shots might cause fever — cytokine release — would typically produce a transient, low-grade response, not a sustained high fever. Fever accompanied by rigors (shaking chills) is a sign of significant infection and should be evaluated medically regardless of recent allergy shot status.

Isolated post-shot fever resolving within 24 hours is not an indication to stop treatment per Cox 2011 PP3. The Cox 2011 Practice Parameter does not list fever as a trigger for dose adjustment or discontinuation in the way that local reactions ≥25 mm or systemic reactions grades 1-4 are listed. If you are experiencing recurring post-shot fevers at multiple injection visits, this pattern should be discussed with your allergist — not because fever alone warrants stopping, but because the clinical picture may indicate that the extract concentration, your injection interval, or a concurrent medical condition needs review. Fever as the sole symptom, resolving, not recurring, is unlikely to affect your treatment plan.